Cong Xu

640 total citations
16 papers, 508 citations indexed

About

Cong Xu is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Cong Xu has authored 16 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Cong Xu's work include Drug Transport and Resistance Mechanisms (3 papers), Cannabis and Cannabinoid Research (3 papers) and Neuropeptides and Animal Physiology (3 papers). Cong Xu is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cannabis and Cannabinoid Research (3 papers) and Neuropeptides and Animal Physiology (3 papers). Cong Xu collaborates with scholars based in United States, China and Belgium. Cong Xu's co-authors include Zeruesenay Desta, Nephi Stella, Wenjie Lu, David A. Flockhart, José A. Cisneros, Giulio G. Muccioli, María L. López-Rodrı́guez, Didier M. Lambert, Eiron Cudaback and Sandra Bajjalieh and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Cong Xu

16 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong Xu United States 12 206 141 106 82 65 16 508
Toshiaki Amamoto Japan 14 135 0.7× 162 1.1× 90 0.8× 47 0.6× 44 0.7× 21 578
Zhi‐Lin Luan China 19 104 0.5× 346 2.5× 120 1.1× 33 0.4× 54 0.8× 56 799
Jerry Muhammad United Kingdom 4 522 2.5× 184 1.3× 75 0.7× 112 1.4× 124 1.9× 5 872
S Rafi United Kingdom 7 269 1.3× 134 1.0× 100 0.9× 27 0.3× 45 0.7× 9 565
Lianxia Guo China 17 48 0.2× 346 2.5× 150 1.4× 62 0.8× 61 0.9× 35 1.0k
Yusaku Komoike Japan 15 301 1.5× 93 0.7× 58 0.5× 64 0.8× 71 1.1× 21 579
W. McKnight Canada 12 404 2.0× 108 0.8× 90 0.8× 66 0.8× 42 0.6× 14 791
Susanna Tse United States 14 68 0.3× 146 1.0× 118 1.1× 61 0.7× 11 0.2× 26 474
Diane D‐S. Tang‐Liu United States 14 207 1.0× 123 0.9× 54 0.5× 46 0.6× 17 0.3× 19 613
Yanke Lin China 15 55 0.3× 324 2.3× 114 1.1× 28 0.3× 42 0.6× 25 843

Countries citing papers authored by Cong Xu

Since Specialization
Citations

This map shows the geographic impact of Cong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xu more than expected).

Fields of papers citing papers by Cong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xu. The network helps show where Cong Xu may publish in the future.

Co-authorship network of co-authors of Cong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Cong Xu. A scholar is included among the top collaborators of Cong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Xu. Cong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Tangzhiming, Qiyun Liu, Xiaoyu Wang, et al.. (2024). Development and validation of a risk prediction model for valve regurgitation in Behçet’s disease. Clinical Rheumatology. 43(5). 1711–1721. 1 indexed citations
2.
Xu, Cong, Tangzhiming Li, Jie Yuan, et al.. (2022). Iron metabolism-related genes reveal predictive value of acute coronary syndrome. Frontiers in Pharmacology. 13. 1040845–1040845. 4 indexed citations
3.
Wang, Hongmei, et al.. (2022). A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer. International Immunopharmacology. 108. 108743–108743. 18 indexed citations
4.
Mou, Yakui, Wentao Guo, Jingjing Qiu, et al.. (2022). A newly identified mutation (c.2029 C > T) in SLC26A4 gene is associated with enlarged vestibular aqueducts in a Chinese family. BMC Medical Genomics. 15(1). 49–49. 2 indexed citations
5.
Horne, Eric A., Philippe Diaz, Patrick J. Cimino, et al.. (2020). A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis. Neuro-Oncology Advances. 3(1). vdaa165–vdaa165. 16 indexed citations
6.
Diaz, Philippe, Eric A. Horne, Cong Xu, et al.. (2018). Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells. European Journal of Medicinal Chemistry. 159. 74–89. 23 indexed citations
7.
Lee, Kyung‐Soon, et al.. (2017). Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells. Journal of Pharmacology and Experimental Therapeutics. 361(2). 219–228. 5 indexed citations
9.
Fung, Susan, Allison E. Cherry, Cong Xu, & Nephi Stella. (2015). Alkylindole-sensitive receptors modulate microglial cell migration and proliferation. Glia. 63(10). 1797–1808. 14 indexed citations
10.
Xu, Cong & Zeruesenay Desta. (2013). In Vitro Analysis and Quantitative Prediction of Efavirenz Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effects on CYPs 2B6, 2C8, 2C9 and 2C19. Drug Metabolism and Pharmacokinetics. 28(4). 362–371. 45 indexed citations
11.
Xu, Cong, Evan T. Ogburn, Yingying Guo, & Zeruesenay Desta. (2012). Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo. Drug Metabolism and Disposition. 40(4). 717–725. 55 indexed citations
12.
Lu, Wenjie, Cong Xu, Zifan Pei, et al.. (2011). The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents. Breast Cancer Research and Treatment. 133(1). 99–109. 57 indexed citations
13.
Marrs, William, Eric A. Horne, Silvia Ortega‐Gutiérrez, et al.. (2011). Dual Inhibition of α/β-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons. Journal of Biological Chemistry. 286(33). 28723–28728. 36 indexed citations
14.
Lu, Wenjie, et al.. (2011). Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms. Chirality. 23(10). 891–896. 61 indexed citations
15.
Muccioli, Giulio G., Cong Xu, Eiron Cudaback, et al.. (2007). Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells. Journal of Neuroscience. 27(11). 2883–2889. 144 indexed citations
16.
Hirata, Roli K., Cong Xu, Rong Dong, et al.. (2004). Efficient PRNP Gene Targeting in Bovine Fibroblasts by Adeno-Associated Virus Vectors. Cloning and Stem Cells. 6(1). 31–36. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026